For latest study has revealed that the various side effects of Pfizer against Covid-19 in 12 to 15 year-olds at the high risk of complications from the infection are likely to be mild to moderate and clear up quickly because of certain coexisting conditions. Healthy children with Covid-19 infection generally have a mild illness, but many coexisting conditions, in particularly neurological conditions, are associated with the various disease.

The UK’s vaccine advisory teams, the Joint Committee on Vaccination and Immunization (JCVI), advised that children aged around 12 and over with severe neurological disabilities, which tend to get recurrent respiratory infections and have complex care needs, should be offered the Covid-19 jab. They had many neurological conditions such as muscular dystrophy and cerebral palsy, plus a range of coexisting medical conditions including congenital heart defects, epilepsy, and immune deficiency, for which they were receiving the drug treatment of many kinds. These high-risk children were therefore shielded to reduce their risk of infection, and would not have been included in early vaccine safety studies. The reported for the various side effects were all mild to moderate, for except one child who experienced severe fatigue and discomfort, combined with increased agitation.